You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 131 No. 6, June 1995 TABLE OF CONTENTS
  Archives
  •  Online Features
  Correspondence: Vignettes
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Sézary's Syndrome and Human Immunodeficiency Virus Infection

Timothy G. Berger, MD
Dermatology Service Building 90, Ward 92, Room 224 San Francisco General Hospital 1001 Potrero Ave San Francisco, CA 94110

Russell L. Kerschmann, MD
San Francisco

Rudolph Roth, MD
Travis Air Force Base, Calif

Karen Schulze; Herschel S. Zackheim, MD
San Francisco

Arch Dermatol. 1995;131(6):739-741.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

We have followed a patient with human immunodeficiency virus (HIV) infection and erythrodermic cutaneous T-cell lymphoma (CTCL). He eventually developed tumor-stage disease and large numbers of circulating atypical helper T cells (Sézary's syndrome). He suffered progression of HIV disease to the acquired immunodeficiency syndrome with a rising helper T-cell count and no development of opportunistic infections.

Report of a Case

A 51-year-old black male airplane mechanic with frequent and long-term expsoure to chemicals and solvents presented in 1988 with widespread erythema, exfoliation, and scaling plaques on the trunk. A serologie test for syphilis was positive at 1:32 and confirmed with a reactive fluorescent treponemal antibody-absorption test. Treatment for syphilis led to no improvement of the eruption but return of the VDRL to negative in 1 year. Serologie testing for HIV was positive. At the time of the diagnosis of HIV, his helper T-cell count was 0.50x109/L and the helper-to-suppressor ratio was 1:1. Over the next 4 years, his skin eruption became more . . . [Full Text PDF of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1995 American Medical Association. All Rights Reserved.